Contact

Representative before the EPO

Company dna harrison goddard foote llp
no operation time available
10 offices
active in Legal Services

Representative before the EPO

Employment test 51 - 200 employees
Company dna hgf ltd
operating since 1995
1151.36
Headquarter in Leeds and 13 offices
active in Legal Services and IP Consulting

Andrew Wells has worked on the following 129 EPO patent applications which have been published in the last five years:

EP11716786

INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS

IPC classification:
A61K 31/155, A61K 31/69, A61K 49/00, C07F 5/02
Applicant:
Mars Inc
Agent:
Celia Mary Keen, J A Kemp
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP11751923

SOLVENT RESISTANT POLYAMIDE NANOFILTRATION MEMBRANES

IPC classification:
B01D 67/00, B01D 69/10, B01D 71/56
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
EXAMINATION REQUESTED
EP11837376

HOLDING TANK-LESS WATER OZONATING SYSTEM USING ELECTROLYTIC DECOMPOSITION OF WATER

IPC classification:
A61L 2/18, A62D 3/38, B01D 19/00, B01F 3/04
Agent:
Multiple attorneys, HGF Limited
Agent:
Multiple attorneys, Harrison Goddard Foote LLP
Status:
GRANT OF PATENT INTENDED
EP11738270

ASYMMETRIC MEMBRANES FOR USE IN NANOFILTRATION

IPC classification:
B01D 67/00, B01D 69/14, B01D 71/62
Applicant:
Imperial Innovations Limited
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
EXAMINATION REQUESTED
EP12722495

CANNABINOIDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN

IPC classification:
A61K 31/05, A61K 31/185, A61K 31/352, A61P 25/02
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
PATENT GRANTED
EP12731151

CANNABINOIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS

IPC classification:
A61K 31/05, A61K 31/185, A61K 31/352, A61P 9/10, A61P 25/00, A61P 25/16, A61P 25/28
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
GRANT OF PATENT INTENDED
EP12735320

N- (2 -AMINOPHENYL) BENZAMIDE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS

IPC classification:
A61K 31/47, A61P 35/00, C07D 217/08, C07D 217/16
Applicant:
Cancer Research Technology Ltd
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11818646

COMPOSITIONS, METHODS AND ARTICLES PRODUCED BY COMPOUNDING POLYAMIDES WITH OLEFIN-MALEIC ANHYDRIDE POLYMERS

IPC classification:
C08K 7/14, C08L 23/08, C08L 35/02, C08L 77/00, C08L 77/02, C08L 77/06
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
EXAMINATION IN PROGRESS
EP12826053

TREATMENT OF WATER TO EXTEND HALF-LIFE OF OZONE

IPC classification:
A61L 2/20, B01F 3/04, B01J 47/00, C01B 13/10, C02F 1/78
Agent:
Multiple attorneys, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12727994

POLYMERIC MATERIAL FOR AN INSULATED CONTAINER

IPC classification:
C08J 9/00, C08L 23/10
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12768940

METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS

IPC classification:
C08F 220/28, C08F 230/02, C08F 230/08, C08F 236/20, C08F 236/22, C08F 283/12, C08F 290/06, G02B 1/04
Agent:
Andrew Wells, HGF Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12759326

BIOCOMPATIBLE MATERIAL

IPC classification:
C07F 9/09, C07F 9/10, C07F 9/572, C08F 30/02, G02B 1/04
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12761793

SHORT DESIGNED PEPTIDES POSSESSING SELECTIVE ACTIONS AGAINST BACTERIA AND CANCER CELLS

IPC classification:
A61K 38/04, C07K 7/06, C08K 7/08
Applicant:
University of Manchester
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13169048

Method for preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation

IPC classification:
A61K 9/00, A61K 9/16, A61K 9/20, A61K 31/167, A61K 31/375, A61K 47/38
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
GRANT OF PATENT INTENDED
EP12770204

PREVENTION AND/OR TREATMENT OF CANCER AND/OR CANCER METASTASIS

IPC classification:
A61K 31/727, A61P 35/04
Applicant:
University of Liverpool
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12761795

A PHARMACEUTICAL COMPOSITION COMPRISING THE PHYTOCANNABINOIDS CANNABIDIVARIN (CBDV) AND CANNABIDIOL (CBD)

IPC classification:
A61K 31/05, A61K 31/352, A61K 36/185, A61K 45/06, A61P 25/08
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP14155284

Fluorescent compound, method for producing the same, and fluorescent resin composition

IPC classification:
C07F 7/08, C09K 11/06
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Status:
PATENT GRANTED
EP12766712

CANNABINOID-2-RECEPTOR AGONISTS

IPC classification:
A61K 31/53, A61P 9/00, A61P 9/10, A61P 17/02, C07D 253/075
Applicant:
Oxford University Innovation Ltd
Agent:
Andrew Wells, HGF Limited
Status:
APPLICATION WITHDRAWN
EP12781004

INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS

IPC classification:
A61K 31/00, A61K 49/00, A61P 35/00, C07F 5/02
Applicant:
Mars Inc
Agent:
Celia Mary Keen, J A Kemp
Agent:
Andrew Wells, HGF Limited
Status:
PATENT GRANTED
EP12780523

PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF BREAST CANCER

IPC classification:
A61K 31/05, A61K 31/352, A61P 35/00
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP12841776

COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM

IPC classification:
A61K 31/415, A61P 29/00, C07D 231/14, C07D 401/12, C07D 405/10, C07D 417/12
Agent:
Andrew Wells, HGF Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12779152

MEMBRANES FOR SEPARATION

IPC classification:
B01D 53/22, B01D 67/00, B01D 69/10, B01D 69/12, B01D 71/48
Applicant:
Imperial Innovations Limited
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12711433

PYRROLOPYRIDINEAMINO DERIVATIVES AS MPS1 INHIBITORS

IPC classification:
A61K 31/437, A61K 31/444, A61P 35/00, C07D 471/04
Applicant:
Cancer Research Technology Ltd
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12756339

POLYMERISABLE MATERIAL

IPC classification:
C07F 9/10, C08F 30/02, G02B 1/04
Agent:
Andrew Wells, HGF Limited
Status:
PATENT GRANTED
EP12784855

3,4-DI-SUBSTITUTED PYRIDINE COMPOUND, METHODS OF USING AND COMPOSITIONS COMPRISING THE SAME

IPC classification:
A61K 31/44, A61P 9/12, A61P 19/00, A61P 19/06
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP12794753

PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES

IPC classification:
A61K 31/05, A61K 31/352, A61P 29/00
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP12795839

TETRAHYDROCANNABIVARIN (THCV) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS

IPC classification:
A61K 31/352, A61P 3/10
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12859961

A PEPTIDE-HYDROGEL COMPOSITE

IPC classification:
A61K 47/48, C08F 226/06
Applicant:
University of Sydney
Agent:
Andrew Wells, HGF Limited
Status:
PATENT GRANTED
EP13167747

Somatostatin vectors

IPC classification:
A61K 38/01, A61K 38/02, A61K 38/03, A61K 38/04, A61K 38/05, A61K 38/06, A61K 38/07, A61K 38/08, A61K 38/09, A61K 38/10, A61K 38/12
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14159934

High-slip stretch film

IPC classification:
B32B 7/00, B32B 7/02, B32B 7/10, B32B 27/00, B32B 27/06, B32B 27/08, B32B 27/30, B32B 27/32, B65D 65/38
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14170863

Composition for hot-melt extrusion and method for producing hot-melt extrusion product using same

IPC classification:
A61K 9/20, A61K 47/38, C08B 11/08
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14153495

Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy

IPC classification:
A61K 31/352, A61P 25/08
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
GRANT OF PATENT INTENDED
EP14169540

Method for producing aqueous enteric coating liquid, solid preparation, and method for producing same

IPC classification:
A61K 9/28, A61K 31/525
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13743245

BIOMATERIALS FOR DELIVERY OF BLOOD EXTRACTS AND METHODS OF USING SAME

IPC classification:
A61K 8/72
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP14173796

Method for producing water-soluble nonionic cellulose ether excellent in storage stability

IPC classification:
C08B 11/00, C08B 11/193
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP13763450

IMIDAZOTRIAZINONE COMPOUNDS

IPC classification:
A01N 43/64, A61K 31/53, C07D 487/00
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13768394

SYSTEM AND PROCESS FOR RECLAIMING SINGLE AND MIXED AMINE SOLVENTS

IPC classification:
B01D 53/96, C07C 209/84
Agent:
Multiple attorneys, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14179921

Method for dehydrating hydrous low-substituted hydroxypropyl cellulose and method for producing low-substituted hydroxypropyl cellulose by using same

IPC classification:
B01D 33/17, B30B 9/12, B30B 9/20, C08B 11/08, C08B 11/20
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14179920

Method for producing water-soluble cellulose ether having low degree of polymerization and method for producing film coating composition comprising same

IPC classification:
C08B 1/06, C08B 1/08, C08B 11/00, C08B 11/20, C08B 15/00, C09D 101/26, D21B 1/04, D21C 9/00, D21H 15/02, D21H 19/34, D21H 19/52
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14150512

Coating composition, drug-containing particle, solid preparation and method for preparing drug-containing particle

IPC classification:
A61K 9/28, C09D 101/26, C09D 101/28
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Status:
PATENT GRANTED
EP14150511

Method for preparing cellulose ether having low degree of polymerization and cellulose ether prepared thereby

IPC classification:
C08B 11/02, C08B 11/08, C09D 101/28
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Status:
PATENT GRANTED
EP13718049

3- (1' -ADAMANTYL) - 1 - AMINOMETHYL - 3, 4 - DIHYDRO - 5, 6 - DIHYDROXY - 1H - 2 - BENZOPYRAN FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH BETA-AMYLOID INDUCED TOXICITY

IPC classification:
A61K 31/353, A61P 25/28
Applicant:
University of Manchester
Agent:
Andrew Wells, HGF Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13785137

GERMANIUM-BASED GLASS POLYALKENOATE CEMENT

IPC classification:
A61B 17/58, A61L 24/02, A61L 24/12, C03C 3/253, C03C 4/08, C03C 12/00
Applicant:
Dalhousie University
Agent:
Multiple attorneys, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13718047

THERAPEUTIC COMPOUNDS

IPC classification:
A61K 31/506, A61P 35/00, C07D 417/04
Agent:
Andrew Wells, HGF Limited
Status:
PATENT GRANTED
EP13712088

RING CONSTRAINED ANALOGS AS ARGINASE INHIBITORS

IPC classification:
A61K 31/00, A61K 49/00, A61P 35/00, C07F 5/02
Applicant:
Mars Inc
Agent:
Celia Mary Keen, J A Kemp
Agent:
Andrew Wells, HGF Limited
Status:
PATENT LIMITED
EP13727309

ANTHRACENYL - TETRALACTAM MACROCYCLES AND THEIR USE IN DETECTING A TARGET SACCHARIDE

IPC classification:
C07D 257/10, G01N 33/66
Applicant:
University of Bristol
Agent:
Andrew Wells, HGF Limited
Agent:
Jakob Wenzel Bumke, Greaves Brewster LLP
Status:
PATENT GRANTED
EP13730628

SULFORAPHANE ISOLATION AND PURIFICATION

IPC classification:
A61K 31/26, A61K 47/48, C07C 331/20, C08B 37/16, C08L 5/16
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13726846

METHOD OF SYNTHESISING SULFORAPHANE

IPC classification:
A61K 31/26, A61K 47/48, C07C 331/20, C08B 37/16, C08L 5/16
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP14192736

Permanent magnet type magnetic field generating apparatus

IPC classification:
H01F 7/02
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12738805

HIGH MOLECULAR WEIGHT CASTOR-OIL-BASED POLYOLS AND USES THEREOF

IPC classification:
C08G 18/36, C08G 18/65, C08G 18/69, C08L 91/00
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
EXAMINATION IN PROGRESS
EP13729798

SYNERGISTIC THERAPIES OF CANNABIDIOL WITH HYPOTHERMIA FOR NEUROPROTECTION

IPC classification:
A61K 31/05, A61M 19/00, A61P 25/00
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Status:
PATENT GRANTED
EP13731470

PHARMACEUTICALLY ACTIVE COMPOUNDS

IPC classification:
A61K 31/437, A61P 35/00, C07D 471/06
Applicant:
Cancer Research Technology Ltd
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12700294

USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY

IPC classification:
A61K 31/05, A61K 31/19, A61K 31/4015, A61P 25/08
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
GRANT OF PATENT INTENDED
EP11712658

USE OF THE PHYTOCANNABINOID CANNABIDIVARIN (CBDV) IN THE TREATMENT OF EPILEPSY

IPC classification:
A61K 31/05, A61K 31/19, A61K 31/352, A61K 31/40, A61K 36/185, A61K 45/06, A61P 25/08
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
EXAMINATION IN PROGRESS
EP13822929

COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS

IPC classification:
A61K 31/54
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13823863

ATX MODULATING AGENTS

IPC classification:
A61K 31/683, C07C 47/575
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13822655

ATX MODULATING AGENTS

IPC classification:
A61K 31/015, A61K 31/4375, A61K 31/44
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13828421

COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS

IPC classification:
A61K 31/122, A61K 31/381, A61K 31/661, C07C 229/34
Applicant:
Biogen MA Inc.
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13828402

COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS

IPC classification:
A61K 31/122, A61K 31/381, A61K 31/661, C07C 229/34
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13760106

INHIBITOR COMPOUNDS

IPC classification:
A61K 31/4375, A61K 31/4725, A61K 31/519, A61P 35/00, C07D 401/04, C07D 401/14, C07D 405/04, C07D 413/14, C07D 471/04, C07D 519/00
Applicant:
Cancer Research Technology Ltd
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13844343

ENALAPRIL COMPOSITIONS

IPC classification:
A61K 31/40, A61P 9/04
Applicant:
University of Kansas
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13786061

NONUNIFORMLY PERFORATED PLASTIC BAG

IPC classification:
B65D 33/01, B65D 77/06, B65D 81/20
Applicant:
Rohm and Haas Company
Applicant:
Dow Global Technologies LLC
Agent:
Fleischer Engels & Partner mbB
Agent:
Andrew Wells, HGF Limited
Status:
PATENT GRANTED
EP13855039

HETEROCYCLIC GLUTAMINASE INHIBITORS

IPC classification:
A61K 31/501, A61P 25/28, A61P 35/00, A61P 37/00, C07D 417/06, C07D 417/14
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13799458

S1P AND/OR ATX MODULATING AGENTS

IPC classification:
A61K 31/40, A61K 31/451, A61K 31/4545, A61K 31/495, C07D 207/08, C07D 211/22, C07D 211/56, C07D 211/62, C07D 211/70, C07D 213/74, C07D 237/22, C07D 239/47, C07D 295/15, C07D 295/155, C07D 401/12
Applicant:
Biogen MA Inc.
Agent:
Andrew Wells, HGF Limited
Status:
The patent has been granted
EP13860670

TREATMENT OF CANCER WITH HETEROCYCLIC INHIBITORS OF GLUTAMINASE

IPC classification:
A61K 31/4245, A61K 31/433, A61K 31/501, A61P 35/00
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13811743

IMPROVED PROCESS FOR THE PREPARATION OF!N-CYANO-S-[1 -(PYRIDIN-3-YL)ETHYL]-S-METHYLSULFILIMINES

IPC classification:
C07D 213/34
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13866319

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

IPC classification:
A01N 25/26
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13873366

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

IPC classification:
A01N 43/40
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13866362

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

IPC classification:
A01N 25/26, A01N 37/46
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13863997

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

IPC classification:
A01N 37/46
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13815613

MODIFIED ATMOSPHERE PACKAGE FOR BANANAS

IPC classification:
A23B 7/152, B65D 81/20, B65D 85/34
Applicant:
Rohm and Haas Company
Applicant:
Dow Global Technologies LLC
Agent:
Fleischer Engels & Partner mbB
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13867917

FUNGICIDAL COMPOSITIONS FOR CONTROLLING LEAF SPOTS IN SUGAR BEETS

IPC classification:
A01N 43/40, A01N 43/54
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13867933

SYNERGISTIC FUNGICIDAL COMPOSITIONS

IPC classification:
A01N 43/40, A01N 43/54
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13868013

N-(SUBSTITUTED)-5-FLUORO-4-IMINO-3-METHYL-2-OXO-3,4-DIHYDROPYRIMIDINE-1 (2H)-CARBOXYLATE DERIVATIVES

IPC classification:
A01N 43/54, A01P 3/00, A61K 31/513
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13867164

SYNERGISTIC FUNGICIDAL COMPOSITIONS

IPC classification:
A01N 43/40, A01N 43/54
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13869394

1-(SUBSTITUTED-BENZOYL)-5-FLUORO-4-IMINO-3-METHYL-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVES

IPC classification:
A61K 31/513
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP14705456

SYSTEMS AND METHODS FOR PLANT STRESS MITIGATION

IPC classification:
A01N 25/00, A01N 27/00
Agent:
Fleischer Engels & Partner mbB
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14707577

METHODS FOR INCREASING CROP YIELD

IPC classification:
A01N 25/00, A01N 27/00, A01P 21/00
Applicant:
Syngenta Participations AG
Agent:
Fleischer Engels & Partner mbB
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14713015

OVERCOATED POWDER PARTICLES

IPC classification:
A01N 25/28, A01N 27/00, A01P 21/00
Applicant:
Syngenta Participations AG
Agent:
Fleischer Engels & Partner mbB
Agent:
Andrew Wells, HGF Limited
Status:
APPLICATION WITHDRAWN
EP14717032

MACROCYCLIC COMPOUNDS AS IRAK4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES

IPC classification:
A61K 31/439, A61P 29/00, C07D 471/22, C07D 498/18, C07D 498/22, C07D 513/18, C07D 513/22
Applicant:
Biogen MA Inc.
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14721638

S1P AND/OR ATX MODULATING AGENTS

IPC classification:
A61K 31/4985, A61K 31/551, A61P 25/00, A61P 29/00, A61P 35/00, C07D 487/04, C07D 519/00
Applicant:
Biogen MA Inc.
Agent:
Andrew Wells, HGF Limited
Status:
APPLICATION WITHDRAWN
EP14773634

MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO

IPC classification:
A01N 43/647, A01P 7/00, A01P 9/00, A01P 19/00, A61K 31/4196, C07D 401/00
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14763824

BUDIODARONE FORMULATIONS

IPC classification:
A61K 31/343, A61P 9/06
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP15166826

THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

IPC classification:
A61K 31/44, A61K 31/444, A61K 31/4965, A61P 9/00, A61P 9/12, A61P 19/06, C07D 213/70, C07D 239/38, C07D 241/18, C07D 401/04, C07D 403/04, C07D 405/04, C07D 417/04
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14767356

POLYMORPHS AND SALTS OF A COMPOUND

IPC classification:
C07D 413/14, G01N 23/207
Agent:
Andrew Wells, HGF Limited
Status:
APPLICATION WITHDRAWN
EP15179111

USE OF MELANOCORTINS TO TREAT INSULIN SENSITIVITY

IPC classification:
A61K 38/00
Applicant:
IPSEN PHARMA S.A.S.
Applicant:
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14718444

A METHOD AND APPARATUS FOR INFUSING ADDITIVE MANUFACTURED OBJECTS AND THE LIKE

IPC classification:
B29B 15/10, B29C 67/00, B29C 71/00, B29C 71/02
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14779348

STEEL FOR BLADES AND METHOD FOR PRODUCING SAME

IPC classification:
C21D 9/46, C22C 38/00, C22C 38/18, C22C 38/50
Applicant:
Hitachi Metals, Ltd.
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14778051

METHOD FOR PRODUCING STEEL FOR BLADES

IPC classification:
C21D 9/46, C22C 38/00, C22C 38/44, C22C 38/50
Applicant:
Hitachi Metals, Ltd.
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP11779904

BORONATES AS ARGINASE INHIBITORS

IPC classification:
A61K 31/69, C07F 5/02, C07F 5/04
Applicant:
Mars Inc
Agent:
Celia Mary Keen, J A Kemp
Agent:
Andrew Wells, HGF Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14770542

IMPACT-MODIFIED POLYAMIDE COMPOSITIONS

IPC classification:
C08L 77/00
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14717843

TETRAHYDROCANNABIVARIN FOR USE IN THE TREATMENT OF NAUSEA AND VOMITING

IPC classification:
A61K 31/352, A61P 1/08
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13882649

GEL FORMULATIONS FOR EXTENDED RELEASE OF VOLATILE COMPOUNDS

IPC classification:
A01N 3/00, A01N 27/00, A01P 21/00
Agent:
Fleischer Engels & Partner mbB
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP13882761

METHODS AND COMPOSITIONS FOR POLYMER MATRIX SYNTHESIZED BY POLYCONDENSATION

IPC classification:
A01N 25/28, A01N 27/00, B01J 13/02, C08K 5/01, C08K 5/17, C08L 5/16, C08L 63/00
Agent:
Fleischer Engels & Partner mbB
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14712820

METHODS OF HANDLING PAPAYA

IPC classification:
A23B 7/14, A23L 3/34
Agent:
Fleischer Engels & Partner mbB
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP15775357

METHODS FOR TREATING HYPOTENSION

IPC classification:
A61K 38/22
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP14732613

USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR INCREASING RADIOSENSITIVITY IN THE TREATMENT OF A BRAIN TUMOUR

IPC classification:
A61K 31/352, A61K 36/185, A61P 35/00
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14732614

THE USE OF PHYTOCANNABINOIDS IN THE TREATMENT OF OVARIAN CARCINOMA

IPC classification:
A61K 31/352, A61K 36/185, A61P 35/00
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP11756786

PHARMACEUTICAL COMPOSITIONS OF GROWTH HORMONE SECRETAGOGUE RECEPTOR LIGANDS

IPC classification:
A61K 9/00, A61K 38/04, A61K 38/08
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14823639

METHODS AND COMPOSITIONS OF GRANULE FORMULATIONS

IPC classification:
A01N 25/12, A01N 27/00, C07C 13/04
Agent:
David Elsy, Withers & Rogers LLP
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14823853

HUMIDITY ACTIVATED FORMULATION FOR VOLATILE COMPOUNDS

IPC classification:
A01N 3/00, A01N 25/18, A01N 27/00, A01N 31/02, A01N 31/16, A01N 35/02, A01N 65/08, A01N 65/40, A01P 1/00, A23B 4/20, A23B 7/14, A23B 7/154, A23L 3/3463, B29C 41/00, B29K 29/00, B29K 105/00, B29L 7/00, B65B 55/04
Agent:
David Elsy, Withers & Rogers LLP
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP15185536

TETRAHYDROCANNABIVARIN (THCV) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS

IPC classification:
A61K 31/155, A61K 31/352, A61K 31/4439, A61K 36/185, A61K 45/06, A61P 3/10
Applicant:
GW Pharma Ltd
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP11707214

MICROGEL COMPOSITIONS

IPC classification:
C08L 33/06
Applicant:
University of Manchester
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15199333

METHOD FOR PRODUCING ALKYL CELLULOSE

IPC classification:
C08B 11/02, C08L 1/28
Applicant:
Shin-Etsu Chemical Co Ltd
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14836721

CONJUGATING MOLECULES TO PARTICLES

IPC classification:
C07K 1/22, C07K 17/14
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP11724508

METHODS FOR IDENTIFYING COMPOSITIONS THAT ALTER WILDTYPE EXPRESSION OF GENES AND PROTEINS IN A PLANT CELL

IPC classification:
C12Q 1/68, G01N 33/50
Applicant:
Rohm and Haas Company
Applicant:
Dow AgroSciences LLC
Agent:
Fleischer Engels & Partner mbB
Agent:
Andrew Wells, HGF Limited
Agent:
polypatent BGL
Status:
GRANT OF PATENT INTENDED
EP11715120

ABUSE-DETERRENT TRANSDERMAL FORMULATIONS OF OPIATE AGONISTS AND AGONIST-ANTAGONISTS

IPC classification:
A61K 9/70, A61K 31/485, A61K 47/38, A61P 25/36
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Andrew Wells, HGF Limited
Status:
PATENT GRANTED
EP14781644

FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1

IPC classification:
A61K 31/357, A61K 31/404, A61K 31/428, A61K 31/436, A61P 35/00, C07D 319/08, C07D 405/12, C07D 405/14, C07D 407/12, C07D 409/12, C07D 417/12, C07D 417/14, C07D 471/04, C07D 487/08, C07D 491/056
Applicant:
Cancer Research Technology Ltd
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14784423

NOVEL FORMULATION

IPC classification:
A61K 9/00, A61K 9/70, A61K 31/445, A61K 47/10
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14784363

NANOPARTICLES

IPC classification:
C08J 3/12, H01B 1/12
Applicant:
University of Manchester
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14854656

PROCESSES FOR THE PREPARATION OF PESTICIDAL COMPOUNDS

IPC classification:
A01N 25/00, A01N 43/56, A01N 47/40, C07D 231/14, C07D 231/40
Applicant:
Dow AgroSciences LLC
Agent:
Andrew Wells, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13150322

Phenoxymethyl heterocyclic compounds

IPC classification:
A61K 31/4985, A61P 25/18
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16151271

ABUSE-DETERRENT TRANSDERMAL FORMULATIONS OF OPIATE AGONISTS AND AGONIST-ANTAGONISTS

IPC classification:
A61K 9/70, A61K 47/38, A61P 25/36
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP11709175

PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER

IPC classification:
A61K 31/05, A61K 31/192, A61K 31/337, A61K 31/352, A61K 31/4188, A61K 36/185, A61K 45/06
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
GW Pharma Ltd
Agent:
Gill Jennings & Every LLP
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
PATENT GRANTED
EP10853305

SNP FOR PREDICTING THE SENSITIVITY TO ANTICANCER TARGETED THERAPEUTIC FORMULATION

IPC classification:
C12Q 1/68
Applicant:
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11761793

IMIDAZOTRIAZINONE COMPOUNDS

IPC classification:
A61K 31/53, A61P 25/00, C07D 487/04
Agent:
Andrew Wells, HGF Limited
Agent:
Andrew Wells, Harrison Goddard Foote LLP
Status:
PATENT GRANTED
EP14825001

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

IPC classification:
A61K 31/44, A61K 31/505, A61K 31/506, A61P 25/02, A61P 35/00, A61P 37/00, C07D 401/14, C07D 403/12, C07D 409/14, C07D 413/14, C07D 417/12, C07D 417/14, C07D 495/04, C07D 513/04
Applicant:
Biogen MA Inc.
Agent:
Holger Carl Tostmann, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP14872860

NOVEL NANODISC CLATHRATES AND USES THEREOF

IPC classification:
C04B 16/00
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP14872256

PRE-EXFOLIATED LAYERED MATERIALS

IPC classification:
B32B 27/08, B32B 27/18, B32B 27/38
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP16167562

USE OF CANNABIDIOL IN COMBINATION WITH ARIPIPRAZOLE

IPC classification:
A61K 31/05, A61K 31/35, A61K 31/352, A61K 36/185, A61K 45/06, A61P 25/18, A61P 25/22
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Agent:
Andrew Wells, HGF Limited
Status:
APPLICATION PUBLISHED
EP15702573

INK FORMULATION

IPC classification:
C01B 31/04, C09D 11/30, C09D 11/52, H01L 21/00, H01L 29/00
Applicant:
University of Manchester
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP15704781

TOPICAL COMPOSITION COMPRISING AN ANTIBACTERIAL AGENT

IPC classification:
A61K 9/00, A61K 31/575, A61K 38/12, A61K 38/14, A61K 47/12, A61K 47/14
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP15707758

QUINOLINE COMPOUNDS

IPC classification:
A61K 31/47, A61K 31/4709, A61P 25/28, C07D 215/26, C07D 401/06, C07D 413/14
Applicant:
Oxford University Innovation Ltd
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP15716749

AGENTS INHIBITING GRANULIN FOR TREATMENT OF CANCER

IPC classification:
A61P 35/00, C07K 14/475
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP15714899

SYNTHETIC PROCESS

IPC classification:
C07D 211/02, C07D 211/14
Applicant:
University of Liverpool
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED
EP15791923

METHODS FOR INHIBITING NECROPTOSIS

IPC classification:
A61K 31/495, A61P 35/00, C07D 239/48
Agent:
Andrew Wells, HGF Limited
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature